Sign up for our complimentary
weekly e-journal

Main Newsletter
Mastery Series
Therapy Series
 
Bookmark and Share | Print Article | Items for the Week Previous | All Articles This Week | Next
This article originally posted and appeared in  DietMedicationAging & DiabetesIssue 671

Metformin May Slow Aging Process

Worms treated with metformin live longer. The drug may slow the aging process by mimicking the effects of dieting....
Advertisement

A recent study grew Caenorhabditis elegans worms in the presence of E.Coli bacteria and observed the effects of metformin on the aging process. The results showed the worms that were treated with metformin had lived longer when the E.Coli strain was sensitive to the medication. In fact, the metformin increased their lifespan by 6 days, which is one-third of their usual life expectancy.

The way that metformin slows the aging process is by changing the metabolism process in the bacteria. By doing so, the bacteria restrict the nutrients that are available to the worm. This process has a similar effect to diet restriction in the body.

To isolate the metabolic pathways affected by metformin, the researchers included strains of E.Coli that had defective genes linked to metabolism and controlled the levels of nutrients available to the bacteria. The results revealed that metformin disturbed the bacteria's metabolism of folate and methionine. These are both building blocks to protein and any disruption can limit the nutrients that are available to the worm. This decrease in nutrients available to the host mimics diet restriction and allows the worm to live longer. However, when the worm was given excess sugar in its diet, the metformin did not delay the aging process.

In the gut, bacteria play an important role in nutrient digestion from food. Metabolic diseases including obesity, diabetes, inflammatory bowel disease, and cancer have been associated with defective gut bacteria. Even though metformin's anti-aging mechanism has not been proven in humans, this study may lead to future ways of preventing metabolic diseases.

Metformin Retards Aging in C. elegans by Altering Microbial Folate and Methionine Metabolism. Cell, 2013; 153 (1): 228 DOI: 10.1016/j.cell.2013.02.035 

Advertisement


 

Bookmark and Share | Print | Category | Home

This article originally posted 05 April, 2013 and appeared in  DietMedicationAging & DiabetesIssue 671

Past five issues: Diabetes Clinical Mastery Series Issue 251 | Issue 791 | Diabetes Clinical Mastery Series Issue 250 | GLP-1 Special Editions July 2015 | Issue 790 |

2015 Most Popular Articles:

Self-Monitoring of Blood Glucose: The Patient's Perspective
Posted July 10, 2015
The Impact of Glucagon-Like Peptide 1 Receptor Agonists on Weight Reduction
Posted July 10, 2015
Diet That Mimics Fasting Appears to Slow Aging
Posted July 03, 2015
Vitamin D3 Supplementation and Weight Loss Prevent Cancer in Older Women
Posted July 10, 2015
Evaluation of Cellphone Application that Records Readings from Glucometer
Posted July 10, 2015
Important Advances in Type 1 Diabetes Research
Posted June 25, 2015
Can the Insulin Patch Become a Reality?
Posted July 03, 2015
New Evidence Suggests Pioglitazone Reduces Dementia Risk 42%
Posted July 03, 2015
Metformin May Increase Mortality in Advanced CKD among Type 2 Patients
Posted July 10, 2015
Liraglutide Reducing Postprandial Hyperglycemia Using Closed Loop System
Posted June 25, 2015


Browse by Feature Writer & Article Category.
A. Lee Dellon, MD | Aaron I. Vinik, MD, PhD, FCP, MACP | Beverly Price | Charles W Martin, DD | Derek Lowe, PhD | Dr. Brian Jakes, Jr. | Dr. Fred Pescatore | Dr. Tom Burke, Ph.D | Eric S. Freedland | Evan D. Rosen | Ginger Kanzer-Lewis | Greg Milliger | Kristina Sandstedt | Laura Plunkett | Leonard Lipson, M.A. | Louis H. Philipson | Maria Emanuel Ryan, DDS, PhD | Marilyn Porter, RD, CDE | Melissa Diane Smith | Michael R. Cohen, RPh, MS, ScD, FASHP | Paul Chous, M.A., OD | Philip A. Wood PhD | R. Keith Campbell, Professor, B.Pharm, MBA, CDE | Richard K. Bernstein, MD | Sheri R. Colberg PhD | Sherri Shafer | Stanley Schwartz, MD, FACP, FACE | Steve Pohlit | Steven V. Edelman, M.D. | Timothy S. Hollingshead |

Cast Your Vote
Would you be interested in a urine test strip product that measures microalbumin and creatinine levels to determine kidney failure risk in your patients?

CME/CE of the Week
Warren Joseph, DPM, FIDSA

Category: General Diabetes
Credits: .75